Fortrea Holdings Inc. (FTRE) vs NeoGenomics, Inc. (NEO)

A side-by-side comparison of Fortrea Holdings Inc. and NeoGenomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FTRE vs NEO

growth of $100 · dividends reinvested · last 3y
FTRE -37.5% (-14.5%/yr)NEO +6.6% (+2.2%/yr)NEO compounded faster over this window
50100Start $100202420252026$63$107
FTRE NEO

FTRE vs NEO: by the numbers

  • •FTRE is the larger company ($1.90B vs $475M market cap).
  • •Both run net losses; FTRE's is the smaller (-3.18% vs -6.77% net margin).
  • •NEO grew revenue faster over the past five years (9.41% vs 1.09% CAGR).

Metrics side by side

Valuation

MetricFTRENEO
Forward P/E23.78101.08
P/S ratio0.710.62
P/B ratio3.630.60
EV / EBITDA31.92N/A
FCF yield7.92%N/A

Profitability

MetricFTRENEO
Gross margin17.11%42.92%
Operating margin0.41%-8.63%
Net margin-3.18%-6.77%
ROE-16.25%-6.60%
ROIC0.62%-5.29%

Growth (annualized)

MetricFTRENEO
Revenue CAGR (5Y)1.09%9.41%
FCF CAGR (5Y)-12.98%N/A
Total return CAGR (5Y)N/A-17.55%

Frequently asked

Which has grown faster, FTRE or NEO?
Over the past five years, NEO grew revenue faster — FTRE at a 1.09% CAGR versus NEO at 9.41%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.